OGESTREL 0.5 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ogestrel 0.5, and what generic alternatives are available?
Ogestrel 0.5 is a drug marketed by Watson Labs and is included in one NDA.
The generic ingredient in OGESTREL 0.5 is ethinyl estradiol; norgestrel. There are twenty-six drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norgestrel profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for OGESTREL 0.5?
- What are the global sales for OGESTREL 0.5?
- What is Average Wholesale Price for OGESTREL 0.5?
Summary for OGESTREL 0.5
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | OGESTREL 0.5 at DailyMed |
US Patents and Regulatory Information for OGESTREL 0.5
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | OGESTREL 0.5/50-21 | ethinyl estradiol; norgestrel | TABLET;ORAL-21 | 075406-001 | Dec 15, 1999 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | OGESTREL 0.5/50-28 | ethinyl estradiol; norgestrel | TABLET;ORAL-28 | 075406-002 | Dec 15, 1999 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
